B-type natriuretic peptide deletion leads to progressive hypertension, associated organ damage, and reduced survival: Novel model for human hypertension

Sara J. Holditch, Claire A. Schreiber, Ryan Nini, Jason M. Tonne, Kah-Whye Peng, Aron Geurts, Howard J. Jacob, John C Jr. Burnett, Alessandro Cataliotti, Yasuhiro H Ikeda

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Altered myocardial structure and function, secondary to chronically elevated blood pressure, are leading causes of heart failure and death. B-type natriuretic peptide (BNP), a guanylyl cyclase A agonist, is a cardiac hormone integral to cardiovascular regulation. Studies have demonstrated a causal relationship between reduced production or impaired BNP release and the development of human hypertension. However, the consequences of BNP insufficiency on blood pressure and hypertension-associated complications remain poorly understood. Therefore, the goal of this study was to create and characterize a novel model of BNP deficiency to investigate the effects of BNP absence on cardiac and renal structure, function, and survival. Genetic BNP deletion was generated in Dahl salt-sensitive rats. Compared with age-matched controls, BNP knockout rats demonstrated adult-onset hypertension. Increased left ventricular mass with hypertrophy and substantially augmented hypertrophy signaling pathway genes, developed in young adult knockout rats, which preceded hypertension. Prolonged hypertension led to increased cardiac stiffness, cardiac fibrosis, and thrombi formation. Significant elongation of the QT interval was detected at 9 months in knockout rats. Progressive nephropathy was also noted with proteinuria, fibrosis, and glomerular alterations in BNP knockout rats. End-organ damage contributed to a significant decline in overall survival. Systemic BNP overexpression reversed the phenotype of genetic BNP deletion. Our results demonstrate the critical role of BNP defect in the development of systemic hypertension and associated end-organ damage in adulthood.

Original languageEnglish (US)
Pages (from-to)199-210
Number of pages12
JournalHypertension
Volume66
Issue number1
DOIs
StatePublished - Jul 4 2015

Fingerprint

Brain Natriuretic Peptide
Hypertension
Survival
Hypertrophy
Fibrosis
Inbred Dahl Rats
Blood Pressure
Human Development
Proteinuria
Young Adult
Thrombosis
Heart Failure
Hormones
Phenotype
Kidney

Keywords

  • b-type natriuretic factor
  • fibrosis
  • hypertrophy

ASJC Scopus subject areas

  • Internal Medicine

Cite this

B-type natriuretic peptide deletion leads to progressive hypertension, associated organ damage, and reduced survival : Novel model for human hypertension. / Holditch, Sara J.; Schreiber, Claire A.; Nini, Ryan; Tonne, Jason M.; Peng, Kah-Whye; Geurts, Aron; Jacob, Howard J.; Burnett, John C Jr.; Cataliotti, Alessandro; Ikeda, Yasuhiro H.

In: Hypertension, Vol. 66, No. 1, 04.07.2015, p. 199-210.

Research output: Contribution to journalArticle

Holditch, Sara J. ; Schreiber, Claire A. ; Nini, Ryan ; Tonne, Jason M. ; Peng, Kah-Whye ; Geurts, Aron ; Jacob, Howard J. ; Burnett, John C Jr. ; Cataliotti, Alessandro ; Ikeda, Yasuhiro H. / B-type natriuretic peptide deletion leads to progressive hypertension, associated organ damage, and reduced survival : Novel model for human hypertension. In: Hypertension. 2015 ; Vol. 66, No. 1. pp. 199-210.
@article{3fe7dc64dc344ca0a6b38ad33b9b0871,
title = "B-type natriuretic peptide deletion leads to progressive hypertension, associated organ damage, and reduced survival: Novel model for human hypertension",
abstract = "Altered myocardial structure and function, secondary to chronically elevated blood pressure, are leading causes of heart failure and death. B-type natriuretic peptide (BNP), a guanylyl cyclase A agonist, is a cardiac hormone integral to cardiovascular regulation. Studies have demonstrated a causal relationship between reduced production or impaired BNP release and the development of human hypertension. However, the consequences of BNP insufficiency on blood pressure and hypertension-associated complications remain poorly understood. Therefore, the goal of this study was to create and characterize a novel model of BNP deficiency to investigate the effects of BNP absence on cardiac and renal structure, function, and survival. Genetic BNP deletion was generated in Dahl salt-sensitive rats. Compared with age-matched controls, BNP knockout rats demonstrated adult-onset hypertension. Increased left ventricular mass with hypertrophy and substantially augmented hypertrophy signaling pathway genes, developed in young adult knockout rats, which preceded hypertension. Prolonged hypertension led to increased cardiac stiffness, cardiac fibrosis, and thrombi formation. Significant elongation of the QT interval was detected at 9 months in knockout rats. Progressive nephropathy was also noted with proteinuria, fibrosis, and glomerular alterations in BNP knockout rats. End-organ damage contributed to a significant decline in overall survival. Systemic BNP overexpression reversed the phenotype of genetic BNP deletion. Our results demonstrate the critical role of BNP defect in the development of systemic hypertension and associated end-organ damage in adulthood.",
keywords = "b-type natriuretic factor, fibrosis, hypertrophy",
author = "Holditch, {Sara J.} and Schreiber, {Claire A.} and Ryan Nini and Tonne, {Jason M.} and Kah-Whye Peng and Aron Geurts and Jacob, {Howard J.} and Burnett, {John C Jr.} and Alessandro Cataliotti and Ikeda, {Yasuhiro H}",
year = "2015",
month = "7",
day = "4",
doi = "10.1161/HYPERTENSIONAHA.115.05610",
language = "English (US)",
volume = "66",
pages = "199--210",
journal = "Hypertension",
issn = "0194-911X",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - B-type natriuretic peptide deletion leads to progressive hypertension, associated organ damage, and reduced survival

T2 - Novel model for human hypertension

AU - Holditch, Sara J.

AU - Schreiber, Claire A.

AU - Nini, Ryan

AU - Tonne, Jason M.

AU - Peng, Kah-Whye

AU - Geurts, Aron

AU - Jacob, Howard J.

AU - Burnett, John C Jr.

AU - Cataliotti, Alessandro

AU - Ikeda, Yasuhiro H

PY - 2015/7/4

Y1 - 2015/7/4

N2 - Altered myocardial structure and function, secondary to chronically elevated blood pressure, are leading causes of heart failure and death. B-type natriuretic peptide (BNP), a guanylyl cyclase A agonist, is a cardiac hormone integral to cardiovascular regulation. Studies have demonstrated a causal relationship between reduced production or impaired BNP release and the development of human hypertension. However, the consequences of BNP insufficiency on blood pressure and hypertension-associated complications remain poorly understood. Therefore, the goal of this study was to create and characterize a novel model of BNP deficiency to investigate the effects of BNP absence on cardiac and renal structure, function, and survival. Genetic BNP deletion was generated in Dahl salt-sensitive rats. Compared with age-matched controls, BNP knockout rats demonstrated adult-onset hypertension. Increased left ventricular mass with hypertrophy and substantially augmented hypertrophy signaling pathway genes, developed in young adult knockout rats, which preceded hypertension. Prolonged hypertension led to increased cardiac stiffness, cardiac fibrosis, and thrombi formation. Significant elongation of the QT interval was detected at 9 months in knockout rats. Progressive nephropathy was also noted with proteinuria, fibrosis, and glomerular alterations in BNP knockout rats. End-organ damage contributed to a significant decline in overall survival. Systemic BNP overexpression reversed the phenotype of genetic BNP deletion. Our results demonstrate the critical role of BNP defect in the development of systemic hypertension and associated end-organ damage in adulthood.

AB - Altered myocardial structure and function, secondary to chronically elevated blood pressure, are leading causes of heart failure and death. B-type natriuretic peptide (BNP), a guanylyl cyclase A agonist, is a cardiac hormone integral to cardiovascular regulation. Studies have demonstrated a causal relationship between reduced production or impaired BNP release and the development of human hypertension. However, the consequences of BNP insufficiency on blood pressure and hypertension-associated complications remain poorly understood. Therefore, the goal of this study was to create and characterize a novel model of BNP deficiency to investigate the effects of BNP absence on cardiac and renal structure, function, and survival. Genetic BNP deletion was generated in Dahl salt-sensitive rats. Compared with age-matched controls, BNP knockout rats demonstrated adult-onset hypertension. Increased left ventricular mass with hypertrophy and substantially augmented hypertrophy signaling pathway genes, developed in young adult knockout rats, which preceded hypertension. Prolonged hypertension led to increased cardiac stiffness, cardiac fibrosis, and thrombi formation. Significant elongation of the QT interval was detected at 9 months in knockout rats. Progressive nephropathy was also noted with proteinuria, fibrosis, and glomerular alterations in BNP knockout rats. End-organ damage contributed to a significant decline in overall survival. Systemic BNP overexpression reversed the phenotype of genetic BNP deletion. Our results demonstrate the critical role of BNP defect in the development of systemic hypertension and associated end-organ damage in adulthood.

KW - b-type natriuretic factor

KW - fibrosis

KW - hypertrophy

UR - http://www.scopus.com/inward/record.url?scp=84941598794&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84941598794&partnerID=8YFLogxK

U2 - 10.1161/HYPERTENSIONAHA.115.05610

DO - 10.1161/HYPERTENSIONAHA.115.05610

M3 - Article

C2 - 26063669

AN - SCOPUS:84941598794

VL - 66

SP - 199

EP - 210

JO - Hypertension

JF - Hypertension

SN - 0194-911X

IS - 1

ER -